Findings from our in vitro and in vivo work revealed that PPARγ is an important pathway involved in HIV-1 brain-associated inflammation and could constitute a potential molecular target in the treatment/prevention of HIV-1 brain inflammation and HAND. Here, PPARG is linked to HIV-associated neurocognitive disorder.